Thinking Outside the Box for Obesity Medication Treatment
CME/CE Expiration Date: 4/25/2024* *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.
With limited options and cost limitations for prescribing anti-obesity medications, experienced obesity medicine specialists recognize the importance of off-label use of medication for obesity treatment. This session will briefly review medications that are known to aid in weight loss but lack FDA approval for use in obesity treatment. The session will also include discussion of long-term use of medications that are only approved by the FDA for short-term use. The program will include an interactive discussion of a number of patient scenarios where alternative medications can be considered for obesity treatment.
The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
The Obesity Medicine Association designates this internet enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
|Access Date||Quiz Result||Score||Actions|